← Back to Search

Voice-Based Platform for Chronic Health Management

N/A
Recruiting
Led By David H Gustafson, PhD
Research Sponsored by University of Wisconsin, Madison
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be ≥60 years old
Have medical record diagnoses of at least 5 chronic conditions of which at least 3 must come from hypertension, hyperlipidemia, obesity, prediabetes or diabetes, or depression
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6, 12, 18 months
Awards & highlights

Study Summary

This trial will test whether a voice-based platform is better for delivering an electronic health intervention to older adults than a text/typing-based platform.

Who is the study for?
This trial is for people aged 60 or older who have at least five chronic health conditions, with hypertension, high cholesterol, obesity, prediabetes/diabetes, or depression being among them. Participants must be willing to share their medical records and allow communication with their primary care provider.Check my eligibility
What is being tested?
The study compares two ways of delivering a health management program called Elder Tree (ET) to seniors with multiple chronic illnesses: one using voice commands through a smart system (ET-Voice), and the other via text on a laptop (ET-Text).See study design
What are the potential side effects?
Since this trial involves non-medical interventions focusing on technology use for health management rather than medications or procedures, traditional side effects are not applicable. However, participants may experience frustration or difficulty in using the technology.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 60 years old or older.
Select...
I have been diagnosed with 5 or more chronic conditions, including at least 3 from a specific list.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6, 12, 18 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6, 12, 18 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in anxiety as assessed by the Patient-Reported Outcomes Measurement Information System (PROMIS) 29 v2.1.
Mental Depression
Change in fatigue as assessed by the Patient-Reported Outcomes Measurement Information System (PROMIS) 29 v2.1.
+4 more
Secondary outcome measures
Change in falls
Change in function and disability
Fetal Distress
+5 more
Other outcome measures
Change in NIH Toolbox Loneliness Survey scores
ElderTree usefulness

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Experimental group (ET-Voice)Experimental Treatment1 Intervention
Participants will receive ElderTree on a smart system.
Group II: Control group (ET-Text)Placebo Group1 Intervention
Participants will receive ElderTree on a laptop.

Find a Location

Who is running the clinical trial?

University of Wisconsin, MadisonLead Sponsor
1,189 Previous Clinical Trials
3,169,075 Total Patients Enrolled
2 Trials studying Multiple Chronic Conditions
403 Patients Enrolled for Multiple Chronic Conditions
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,838 Previous Clinical Trials
47,851,183 Total Patients Enrolled
1 Trials studying Multiple Chronic Conditions
346 Patients Enrolled for Multiple Chronic Conditions
David H Gustafson, PhDPrincipal InvestigatorUniversity of Wisconsin, Madison
6 Previous Clinical Trials
1,666 Total Patients Enrolled
1 Trials studying Multiple Chronic Conditions
346 Patients Enrolled for Multiple Chronic Conditions

Media Library

Elder Tree Clinical Trial Eligibility Overview. Trial Name: NCT05240534 — N/A
Multiple Chronic Conditions Research Study Groups: Control group (ET-Text), Experimental group (ET-Voice)
Multiple Chronic Conditions Clinical Trial 2023: Elder Tree Highlights & Side Effects. Trial Name: NCT05240534 — N/A
Elder Tree 2023 Treatment Timeline for Medical Study. Trial Name: NCT05240534 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Which objectives are this experiment striving to accomplish?

"The aims of this medical study, to be tracked over a Baseline and 6, 12, 18 month period, are the alteration in sleep quality monitored by the Patient-Reported Outcomes Measurement Information System (PROMIS) 29 v2.1., as well as modifications in symptom distress assessed by the General Symptom Distress Scale & Bayliss Disease Burden Scale, an evaluation of wellbeing via The World Health Organization- Five Well-Being Index (WHO-5), and ultimately a transformation in overall ElderTree use across the 12 months intervention approximated through logons."

Answered by AI

Are there any available slots for participants in this investigation?

"Affirmative. Clinicaltrials.gov reveals that this trial is open for enrolment, having been originally posted on April 29th 2022 and subsequently edited on May 6th of the same year."

Answered by AI

How many participants are being included in this research endeavor?

"Correct. Clinicaltrials.gov records that the trial, first posted on April 29th 2022, is actively recruiting patients for participation. A total of 356 participants are needed from a single medical site."

Answered by AI

Who else is applying?

What state do they live in?
Wisconsin
What site did they apply to?
University of Wisconsin
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
0
~279 spots leftby Apr 2027